Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells

Roles of CD38 in the Immune Response to Infection

(2020) Estibaliz Glaría et al.   Cells

In vivo reprogramming drives Kras-induced cancer development

(2018) Hirofumi Shibata et al.   Nature Communications

Downregulation of Endothelin Receptor B Contributes to Defective B Cell Lymphopoiesis in Trisomy 21 Pluripotent Stem Cells

(2018) Glenn A. MacLean et al.   Scientific Reports

Cellular context-dependent consequences ofApcmutations on gene regulation and cellular behavior

(2017) Kyoichi Hashimoto et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

(2017) Michiru Nishita et al.   Scientific Reports

Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells

(2016) Akinobu Ota et al.   JOURNAL OF CELL SCIENCE

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

(2016) John G Doench et al.   NATURE BIOTECHNOLOGY

Neutrophil alphabet

(2013) A. S. Morgan et al.   BLOOD

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

(2012) N Hosen et al.   LEUKEMIA

CD19−CD45low/−CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells

(2012) D Kim et al.   LEUKEMIA

Genetic variegation of clonal architecture and propagating cells in leukaemia

(2010) Kristina Anderson et al.   NATURE

t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals

(2009) Y Lecluse et al.   LEUKEMIA

AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

(2008) Marta Chesi et al.   CANCER CELL